Skip to main content
. 2022 Dec 2;8(48):eadc9970. doi: 10.1126/sciadv.adc9970

Fig. 2. Primary outcome data.

Fig. 2.

(A) Average Clinician-Administered PTSD Scale (CAPS) scores were decreased by 55.4% 6 months (mo) after DBS relative to baseline. (B) Of the four patients (pt) included in our trial, two (#1 and #2) were considered to be responders (average CAPS improvement of 87.5%), one (#3) was a partial responder (35% improvement), and one (#4) was a nonresponder (12% improvement). Wks; weeks, mo, months.